All-trans retinoic acid-loaded lipid nanoparticles as a transdermal drug delivery carrier

Pharmaceutical Development and Technology

Volumn 19, Issue 2, 2014, Pages 164-172

  Charoenputtakhun, Ponwanit ^a   Opanasopit, Praneet ^a   Rojanarata, Theerasak ^a   Ngawhirunpat, Tanasait ^a  

^a SILPAKORN UNIVERSITY   (Thailand)

Author keywords

All trans retinoic acid; Lipid nanoparticles; Nanostructured lipid carriers; Solid lipid nanoparticles; Transdermal drug delivery

Indexed keywords

BUTYLCRESOL; LINOLEIC ACID; MEDIUM CHAIN TRIACYLGLYCEROL; OLEIC ACID; PALMITIC ACID; PHOSPHATIDYLCHOLINE; POLYSORBATE 80; RETINOIC ACID; SOLID LIPID NANOPARTICLE; SOYBEAN OIL; WATER;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; TRANSDERMAL DRUG ADMINISTRATION; ZETA POTENTIAL;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTINEOPLASTIC AGENTS; DRUG CARRIERS; LIPIDS; NANOPARTICLES; OILS; SKIN; SKIN ABSORPTION; SNAKES; TRETINOIN;

EID: 84899804509     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.3109/10837450.2013.763261     Document Type: Article

References (29)

1. Lucek RW, Colburn WA. Clinical pharmacokinetics of the retinoids. Clin Pharmacokinet 1985;10:38-62.
2. Walters KA, Brain KR. Dermatological and transdermal formulations. New York: Marcel Dekker; 2002:319-39.
3. Muller RH, Radtke M, Wissing SA. Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm 2002; 242:121-8.
4. Fang JY, Fang CL, Liu CH, Su YH. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Eur J Biopharm 2008;70:633-40.
5. Stecova J, Mehnert W, Blaschke T, et al. Cyproterone acetate loading to lipid nanoparticles for topical acne treatment: particle characterization and skin uptake. Pharm Res 2007;24:991-1000.
6. Chinsriwongkul A, Opanasopit P, Ngawhirunpat T, et al. Physicochemical properties of lipid emulsions formulated with high-load all-trans retinoic acid. PDA J Pharm Sci Technol 2007;61:461-71.
7. Chern WH, Thakker KD. Development and validation of in vitro release tests for semisolid dosage forms-case study. Dissolut Technol 2003;10:10-15.
8. Duangjit S, Opanasopit P, Rojanarata T, Ngawhirunpat T. Characterization and in vitro skin permeation of meloxicam-loaded liposomes versus transfersomes. J Drug Deliv 2011;2011:1-9.
9. Wang JJ, Liu KS, Sung KC, et al. Lipid nanoparticles with different oil/fatty ester ratios as carriers of buprenorphine and its prodrugs for injection. Eur J Pharm Sci 2009;38:138-46.
10. Yuechao DU. Fabrication and characterization of low crystalline curcumin loaded lipid nanoparticles [dissertation]. New Brunswick (NJ): New Brunswick University; 2011.
11. Driscoll DF, Giampietro K, Wichelhaus DP, et al. Physicochemical stability assessments of lipid emulsions of varying oil composition. Clin Nutr 2001;20:151-7.
12. Kovacevic A, Savic S, Vuleta G, et al. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure. Int J Pharm 2011;406:163-72.
13. Qingyi XQ, Nakajima M, Liu Z, Shiina T. Soybean-based surfactants and their applications. In: Ng T-B, ed. Soybean - applications and technology. Rijeka, Croatia: InTech 2011:343-64.
14. Waraho T, Clements DJ, Decker EA. Impact of free fatty acid concentration and structure on lipid oxidation in oil-in-water emulsions. Food Chem 2011;129:854-9.
15. Chinsriwongkul A, Chareanputtakhun P, Ngawhirunpat T, et al. Nanostructured lipid carriers (NLC) for parenteral delivery of an anticancer drug. AAPS Pharm Sci Tech 2012;13:150-8.
16. Souto EB, Wissing SA, Barbosa CM, Müller RH. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm 2004;278:71-7.
17. Fang JY, Fang CL, Liu CH, Su YH. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Eur J Biopharm 2008;70:633-40.
18. Souto EB, Muller RH. Nanostructured lipid carriers: a novel generation of solid lipid drug carriers. Pharm Tech Eur 2005;17:45-50.
19. Souto EB, Müller RH. The use of SLN and NLC as topical particulate carriers for imidazole antifungal agents. Int J Pharm 2006;61:431-7.
20. Müller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 2002;54:S131-55.
21. Teeranachaideekul V, Souto EB, Junyaprasert VB, Muller RH. Cetylpalmitate-based NLC for topical delivery of Coenzyme Q10: development, physicochemical characterization and in vitro release studies. Eur J Pharm Biopharm 2007;67:141-8.
22. Teeranachaideekul V, Boonme P, Souto EB, et al. Influence of oil content on physicochemical properties and skin distribution of Nile red-loaded NLC. J Control Release 2008;128:134-41.
23. Wissing SA, Muller RH. The influence of the crystallinity of lipid nanoparticles on their occlusive properties. Int J Pharm 2002; 242:377-9.
24. Pardeike J, Hommoss A, Mü ller RH. Lipid nanoparticles in cosmetic and pharmaceutical dermal products. Int J Pharm 2009; 366:170-84.
25. Santoyo S, Arellano A, Ygartua P, Martin P. Penetration enhancer effects on the in vitro percutaneous absorption of piroxicam through rat skin. Int J Pharm 1995;117:219-24.
26. Barry BW. Mode of action of penetration enhancers in human skin. J Control Release 1987;6:85-97.
27. Heurtault B, Saulnier P, Pech B, et al. Physico-chemical stability of colloidal lipid particles. Biomaterials 2003;24:4283-300.
28. Freitas C, Muller RH. Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN) dispersions. Int J Pharm 1998;168:221-9.
29. Teeranachaideekul V, Muller RH, Junyaprasert VB. Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC)-effects of formulation parameters on physicochemical stability. Int J Pharm 2007;340:198-206.